Status:
COMPLETED
Fascia Lata Allograft Versus Subepithelial Connective Tissue Grafts in the Peri-Implant Mucosal Thickness Enhancement.
Lead Sponsor:
Mohamed Hamdy Helal
Collaborating Sponsors:
Tanta University
Conditions:
Implant Tissue Failure
Eligibility:
All Genders
30-55 years
Phase:
NA
Brief Summary
The aim of this, randomized clinical trial is to determine the clinical efficacy of fascia lata allograft in terms of peri-implant mucosal augmentation, as compared to autologous sub epithelial connec...
Detailed Description
The aim of this, randomized clinical trial is to determine the clinical efficacy of fascia lata allograft in terms of peri-implant mucosal augmentation, as compared to autologous sub epithelial connec...
Eligibility Criteria
Inclusion
- Ability to maintain good oral hygiene as evidenced in recall visits. Aged 30 to 55 years. Stable periodontal condition and missing one single tooth (maxillary anterior teeth and premolars) with adjacent teeth present and thin mucosal phenotype (\< 2mm bucco- lingual thickness).
Exclusion
- Uncontrolled diabetes mellitus. Females who were pregnant, or attempting to become pregnant, and nursing mothers.
- Acute infection in the area intended for implant placement.
Key Trial Info
Start Date :
December 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04679922
Start Date
December 10 2019
End Date
November 18 2020
Last Update
December 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of dentistry Tanta University
Tanta, Egypt, 31773